4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-281119
Director sold 263,962 shares at an average $20.70 ($5,464,611)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2026-06-22 | Sale 10b5-1 | −190,676 | $20.57 | $3,922,263 | 3,921,542 | I |
| Kersten Dirk Director | 2026-06-23 | Sale 10b5-1 | −71,629 | $21.04 | $1,506,766 | 3,849,913 | I |
| Kersten Dirk Director | 2026-06-23 | Sale 10b5-1 | −1,657 | $21.47 | $35,583 | 3,848,256 | I |
| Open-market sales · 263,962 sh · avg $20.70 · $5,464,611 | |||||||
Loading xslF345X06/ownership.xml…